Citations

Citations to this article as recorded by  

• North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
  Raed Alhusayen, Serena Dienes, Megan Lam, Afsaneh Alavi, Ali Alikhan, Maria Aleshin, Emad Bahashwan, Steve Daveluy, Noah Goldfarb, Amit Garg, Wayne Gulliver, Tarannum Jaleel, Alexa B. Kimball, Mark G. Kirchhof, Joslyn Kirby, Joi Lenczowski, Hadar Lev-Tov,
  Journal of the American Academy of Dermatology.2025; 92(4): 825.     CrossRef
• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología.2024; 31(3): 290.     CrossRef
• Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review
  Wei Huang, Xinxing Zhang, Li Zhang, Xiaosong Dai, Heping Chen, Qin Xie
  BMC Pregnancy and Childbirth.2024;[Epub]     CrossRef
• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología (English Edition).2024; 31(3): 290.     CrossRef
• Ulcerative Colitis in Pregnancy: A Japanese Multicenter Cohort Study Focusing on Their Mutual Influence
  Yuichi Shimodate, Akiko Shiotani, Ken-ichi Tarumi, Hiroshi Matsumoto, Osamu Handa, Noriaki Tomioka, Naoyuki Nishimura, Kazuhiro Matsueda, Hirokazu Mouri, Motowo Mizuno
  Internal Medicine.2024;[Epub]     CrossRef
• The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
  Yu Chen, Guolin Zhang, Yuewen Yang, Shuangshuang Zhang, Haozheng Jiang, Kang Tian, Arenbaoligao, Dapeng Chen
  Biomedicine & Pharmacotherapy.2023; 157: 114081.     CrossRef
• Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy
  Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Baw
  Saudi Journal of Gastroenterology.2023;[Epub]     CrossRef
• Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis
  Ole Haagen Nielsen, John Mark Gubatan, Carsten Bogh Juhl, Sarah Elizabeth Streett, Cynthia Maxwell
  Clinical Gastroenterology and Hepatology.2022; 20(1): 74.     CrossRef
• British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
  Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Se
  Rheumatology.2022;[Epub]     CrossRef
• Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis
  Yang Zhang, Dandan Li, Heng Guo, Weina Wang, Xingang Li, Su Shen
  Current Pharmaceutical Design.2021; 27(19): 2317.     CrossRef
• Exposure to Infliximab During Pregnancy: Post-Marketing Experience
  Anja Geldhof, Jennifer Slater, Michael Clark, Urmila Chandran, Danielle Coppola
  Drug Safety.2020; 43(2): 147.     CrossRef
• The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  The Korean Journal of Internal Medicine.2020; 35(1): 41.     CrossRef
• The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  Journal of Rheumatic Diseases.2020; 27(1): 4.     CrossRef
• Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies
  Nicole W Tsao, Nevena Rebic, Larry D Lynd, Mary A De Vera
  Rheumatology.2020; 59(8): 1808.     CrossRef
• Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review
  N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur, H. J. M. J. Crijns
  Drugs.2020; 80(16): 1699.     CrossRef
• Pregnancy and Neuromyelitis Optica Spectrum Disorder – Reciprocal Effects and Practical Recommendations: A Systematic Review
  Rohan D'Souza, Danielle Wuebbolt, Katarina Andrejevic, Rizwana Ashraf, Vanessa Nguyen, Nusrat Zaffar, Dalia Rotstein, Ahraaz Wyne
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
  Ayumi Ito, Bunei Iizuka, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
  Internal Medicine.2018; 57(2): 159.     CrossRef
• The use of biologics and small molecules in pregnant patients with rheumatic diseases
  Maria Gerosa, Lorenza Maria Argolini, Carolina Artusi, Cecilia Beatrice Chighizola
  Expert Review of Clinical Pharmacology.2018; 11(10): 987.     CrossRef
• Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
  Ji Min Lee, Yoon Jae Kim, Kang-Moon Lee, Hyuk Yoon, Bo-In Lee, Dae Bum Kim, Donghoon Kang
  Scandinavian Journal of Gastroenterology.2018; 53(10-11): 1280.     CrossRef
• Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis
  Begoña Gonzalez-Suarez, Shreyashee Sengupta, Alan C Moss
  World Journal of Gastroenterology.2017; 23(45): 8082.     CrossRef
• Maternal and fetal outcomes in pregnant Japanese women with inflammatory bowel disease: our experience with a series of 23 cases
  Naoki Minami, Minoru Matsuura, Yorimitsu Koshikawa, Satoshi Yamada, Yusuke Honzawa, Shuji Yamamoto, Hiroshi Nakase
  Intestinal Research.2017; 15(1): 90.     CrossRef
• Concerns in pregnancy and childbirth of women with inflammatory bowel disease
  Sung-Ae Jung
  Intestinal Research.2016; 14(2): 107.     CrossRef
• Common Adverse Effects of Anti-TNF Agents on Gestation
  Zacharias Fasoulakis, Panagiotis Antsaklis, Nikolaos Galanopoulos, Emmanuel Kontomanolis
  Obstetrics and Gynecology International.2016; 2016: 1.     CrossRef

Citations

Citations to this article as recorded by  

• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy
  Ahmed B. Bayoumy, A. R. Ansari, C. J. J. Mulder, K. Schmiegelow, Timothy Florin, N. K. H. De Boer
  Clinical Pharmacokinetics.2024; 63(8): 1089.     CrossRef
• Azathioprine for people with multiple sclerosis
  Ben Ridley, Francesco Nonino, Elisa Baldin, Ilaria Casetta, Gerardo Iuliano, Graziella Filippini
  Cochrane Database of Systematic Reviews.2024;[Epub]     CrossRef
• Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
  Jiryeon Jang, Sehoon Jeong
  BioChip Journal.2023; 17(4): 403.     CrossRef
• Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
  Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
  Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub]     CrossRef
• A review article of inflammatory bowel disease treatment and pharmacogenomics
  Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
  Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub]     CrossRef
• Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review
  Devendra Desai, Anuraag Jena, Vishal Sharma, Toshifumi Hibi
  Expert Review of Clinical Pharmacology.2023; 16(7): 643.     CrossRef
• Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study
  Yoon-Zi Kim, Ben Kang, Eun-Sil Kim, Yiyoung Kwon, Yon-Ho Choe, Mi-Jin Kim
  Biomedicines.2023; 11(9): 2575.     CrossRef
• Effect of NUDT15 polymorphisms on early hematological safety of low‐dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study
  Xingli Zhou, Liangliang Cheng, Yiyi Wang, Hui Gou, Ke Ju, TianJiao Lan, Tongying Zhan, GaoJie Li, Yuanxia Gu, Yeting Sun, Yan Xu, Yukun Sun, Yanhong Zhou, Wei Li
  The Journal of Dermatology.2022; 49(4): 402.     CrossRef
• Use of thiopurines in inflammatory bowel disease: an update
  Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Ra
  Intestinal Research.2022; 20(1): 11.     CrossRef
• Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder
  Wenjuan Huang, Liang Wang, Junhui Xia, Wenyu Li, Min Wang, Jian Yu, Qinying Li, Bei Wang, Juyuan Pan, Lei Du, Jianhua Ma, Hongmei Tan, Xuechun Chang, Chuanzhen Lu, Chongbo Zhao, Jiahong Lu, Lei Zhou, Jingzi ZhangBao, Chao Quan
  European Journal of Neurology.2022; 29(8): 2343.     CrossRef
• Minimal risk of lymphoma and non‐melanoma skin cancer despite long‐term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India
  Mukesh Kumar Ranjan, Bhaskar Kante, Sudheer Kumar Vuyyuru, Peeyush Kumar, Sandeep K Mundhra, Rithvik Golla, Raju Sharma, Peush Sahni, Prasenjit Das, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1544.     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis
  Qiang Miao, Lin Yan, Yanhong Zhou, Yi Li, Yuangao Zou, Lanlan Wang, Yangjuan Bai, Junlong Zhang
  Scientific Reports.2021;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease
  Kang Chao, Yibiao Huang, Xia Zhu, Jian Tang, Xueding Wang, Lang Lin, Huili Guo, Caibin Zhang, Miao Li, Qingfan Yang, Jie Huang, Lingna Ye, Pinjin Hu, Min Huang, Qian Cao, Xiang Gao
  Alimentary Pharmacology & Therapeutics.2021; 54(9): 1124.     CrossRef
• NUDT15: A bench to bedside success story
  Ann M. Moyer
  Clinical Biochemistry.2021; 92: 1.     CrossRef
• Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
  Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su-on Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Sexual Dysfunction and Fertility Problems in Men with Inflammatory Bowel Disease
  Yong Eun Park, Tae Oh Kim
  The World Journal of Men's Health.2020; 38(3): 285.     CrossRef
• Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases
  Ji Young Chang, Soo Jung Park, Eun Suk Jung, Sung-Ae Jung, Chang Mo Moon, Jaeyoung Chun, Jae Jun Park, Eun Sun Kim, Yehyun Park, Tae-Il Kim, Won Ho Kim, Jae Hee Cheon
  Clinical Gastroenterology and Hepatology.2020; 18(9): 2010.     CrossRef
• Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
  Hiroshi Nakase
  Gut and Liver.2020; 14(1): 7.     CrossRef
• Adjustment of azathioprine dose should be based on a lower 6‐TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers
  Ben Kang, Tae Jun Kim, Jaeyoung Choi, Sun‐Young Baek, Soohyun Ahn, Rihwa Choi, Soo‐Youn Lee, Yon Ho Choe
  Alimentary Pharmacology & Therapeutics.2020; 52(3): 459.     CrossRef
• NUDT15 genotyping during azathioprine treatment in patients with inflammatory bowel disease: implications for a dose-optimization strategy
  Ye Xu, Yu-Qi Qiao, Han-Yang Li, Mi Zhou, Chen-Wen Cai, Jun Shen, Zhi-Hua Ran
  Gastroenterology Report.2020; 8(6): 437.     CrossRef
• Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone
  Xing‐Li Zhou, Tong‐Ying Zhan, Yan‐Hong Zhou, Krista Shrestha, Tian‐Jiao Lan, Wei Li
  Dermatologic Therapy.2020;[Epub]     CrossRef
• Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn’s disease who turned out to possess homozygous mutations in NUDT15 R139C
  Jaewoan Bae, Byung-Ho Choe, Ben Kang
  Yeungnam University Journal of Medicine.2020; 37(4): 332.     CrossRef
• NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine‐induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India
  Rupa Banerjee, Vishnubhotla Venkata Ravikanth, Partha Pal, Govardhan Bale, Urmila Steffie Avanthi, Idan Goren, B. Ganesh Girish, Sasikala Mitnala, D. Nageshwar Reddy
  Alimentary Pharmacology & Therapeutics.2020; 52(11-12): 1683.     CrossRef
• Improving the quality of care for inflammatory bowel disease
  Byong Duk Ye, Simon Travis
  Intestinal Research.2019; 17(1): 45.     CrossRef
• NUDT15 Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis
  Xiaoli Fan, Dandan Yin, Ruoting Men, Heng Xu, Li Yang
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics
  Ji Young Chang, Jae Hee Cheon
  Digestive Diseases and Sciences.2019; 64(9): 2395.     CrossRef
• Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn’s disease patients
  Xia Zhu, Kang Chao, Miao Li, Wen Xie, Hong Zheng, Jin-Xin Zhang, Pin-Jin Hu, Min Huang, Xiang Gao, Xue-Ding Wang
  World Journal of Gastroenterology.2019; 25(38): 5850.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis
  Sarah Cargnin, Armando A. Genazzani, Pier Luigi Canonico, Salvatore Terrazzino
  Pharmacological Research.2018; 135: 102.     CrossRef
• Treatment of Autoimmune Bullous Disorders in Pregnancy
  Carolyn J. Kushner, Josef Symon S. Concha, Victoria P. Werth
  American Journal of Clinical Dermatology.2018; 19(3): 391.     CrossRef
• Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
  Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
  Intestinal Research.2018; 16(2): 216.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 4.     CrossRef
• Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease
  Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang
  World Journal of Gastroenterology.2018; 24(8): 941.     CrossRef
• NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients
  Xiang Fei, Qing Shu, Huaijun Zhu, Bingzhu Hua, Shiying Wang, Ling Guo, Yun Fang, Weihong Ge
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Pharmacotherapy of ulcerative colitis – current status and emerging trends
  Hilal Ahmad, Vijay L. Kumar
  Journal of Basic and Clinical Physiology and Pharmacology.2018; 29(6): 581.     CrossRef
• Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment
  Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef
• Postoperative course of Crohn disease according to timing of bowel resection
  Ji Min Lee, Kang-Moon Lee, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, Dong Soo Han, Chang Kyun Lee, Hyun-Ju Park
  Medicine.2018; 97(16): e0459.     CrossRef
• Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
  Sheng Zhang Lim, Eng Wee Chua
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• NUDT15,FTO, andRUNX1genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
  Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura
  Intestinal Research.2017; 15(3): 328.     CrossRef
• Second Korean Guideline for the Management of Ulcerative Colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
• Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
  Jong Pil Im
  Intestinal Research.2017; 15(2): 147.     CrossRef
• Second Korean guidelines for the management of ulcerative colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  Intestinal Research.2017; 15(1): 7.     CrossRef
• Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease
  Kang Chao, Xueding Wang, Qian Cao, Jiaming Qian, Kaichun Wu, Xia Zhu, Hong Yang, Jie Liang, Lang Lin, Zicheng Huang, Yu Zhang, Yibiao Huang, Yinghao Sun, Xianmin Xue, Min Huang, Pinjin Hu, Ping Lan, Xiang Gao
  Inflammatory Bowel Diseases.2017; 23(9): 1592.     CrossRef
• Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
  Abhinav Vasudevan, Peter R Gibson, Daniel R van Langenberg
  World Journal of Gastroenterology.2017; 23(35): 6385.     CrossRef
• Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
  Chang Soo Eun
  Gut and Liver.2017; 11(1): 3.     CrossRef
• Second Korean Guidelines for the Management of Crohn's Disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
• Second Korean guidelines for the management of Crohn's disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  Intestinal Research.2017; 15(1): 38.     CrossRef
• Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study
  Sang Hyoung Park, Sung Wook Hwang, Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Ho-Su Lee, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim, Suk-Kyun Yang
  Digestive Diseases and Sciences.2016; 61(7): 2060.     CrossRef
• Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn’s disease patients
  Qiuyuan Liu, Yanyan Wang, Qiao Mei, Wei Han, Jing Hu, Naizhong Hu
  Scandinavian Journal of Gastroenterology.2016; 51(9): 1093.     CrossRef
• NUDT15 polymorphisms are better than thiopurine S‐methyltransferase as predictor of risk for thiopurine‐induced leukopenia in Chinese patients with Crohn's disease
  X. Zhu, X.‐D. Wang, K. Chao, M. Zhi, H. Zheng, H.‐L. Ruan, S. Xin, N. Ding, P.‐J. Hu, M. Huang, X. Gao
  Alimentary Pharmacology & Therapeutics.2016; 44(9): 967.     CrossRef
• Influences ofXDHgenotype by gene–gene interactions with SUCLA2 for thiopurine-induced leukopenia in Korean patients with Crohn’s disease
  Soo-Kyung Park, Myunghee Hong, Byong Duk Ye, Kyung-Jo Kim, Sang Hyoung Park, Dong-Hoon Yang, Sung-Wook Hwang, Min Seob Kwak, Ho-Su Lee, Kyuyoung Song, Suk-Kyun Yang
  Scandinavian Journal of Gastroenterology.2016; 51(6): 684.     CrossRef
• Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea
  Ho-Su Lee, Jaewon Choe, Hyo Jeong Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim, Suk-Kyun Yang
  Intestinal Research.2016; 14(3): 258.     CrossRef
• Six Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease
  Ho-Su Lee, Kyung-Wook Jo, Tae Sun Shim, Jin Woo Song, Hyo Jeong Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim, Suk-Kyun Yang
  Journal of Crohn's and Colitis.2015; 9(11): 1053.     CrossRef